Last10K.com

Cvs Health Corp (CVS) SEC Filing 10-K Annual Report for the fiscal year ending Friday, December 31, 2021

SEC Filings

CVS Valuations

Intrinsic Value
Financial Stability
Financial Ratios
Insider Trades
Manager Portfolios
Notifications

CVS Annual Reports

CVS Quarterly Reports

CVS Corporate News

Cvs Health Corp

HISTORY TOOLS
CIK: 1796458 Ticker: CVS
0000064803false00000648032022-01-112022-01-11

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):January 11, 2022
cvs-20220111_g1.jpg
CVS HEALTH CORPORATION
(Exact name of registrant as specified in its charter)
Delaware001-0101105-0494040
(State or other jurisdiction of incorporation)(Commission
File Number)		(IRS Employer
Identification No.)

One CVS Drive, Woonsocket, Rhode Island        02895
(Address of principal executive offices)            (Zip Code)

Registrant’s telephone number, including area code:         (401) 765-1500
Former name or former address, if changed since last report:    N/A

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.01 per shareCVSNew York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐



The following information was filed by Cvs Health Corp (CVS) on Tuesday, January 11, 2022 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Cvs Health Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Cvs Health Corp.

Continue

Assess how Cvs Health Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Cvs Health Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
Financial
Legal
Revenue
Other
Filter Subcategory:
All
Dividend
Income
Expense
Product
Earnings
Debt
Cash Flow
Shares
Other
Inside Cvs Health Corp's 10-K Annual Report:

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Audit Information
Cover Page
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Comprehensive Income
Consolidated Statements Of Operations
Consolidated Statements Of Shareholders' Equity
Consolidated Statements Of Shareholders' Equity (Parentheticals)
Borrowings And Credit Arrangements
Borrowings And Credit Arrangements (Tables)
Borrowings And Credit Arrangements - Debt Maturities (Details)
Borrowings And Credit Arrangements - Long-Term Borrowings (Details)
Borrowings And Credit Arrangements - Schedule Of Debt (Details)
Borrowings And Credit Arrangements - Short-Term Borrowings (Details)
Commitments And Contingencies
Commitments And Contingencies (Details)
Divestitures
Divestitures - Narrative (Details)
Earnings Per Share
Earnings Per Share (Details)
Earnings Per Share (Tables)
Fair Value
Fair Value (Tables)
Fair Value - Carrying Value And Fair Value Classified By Level (Details)
Fair Value - Changes In Level 3 Financial Assets (Details)
Fair Value - Fair Value Measurements (Details)
Fair Value - Gross Transfers Into (Out Of) Level 3 (Details)
Fair Value - Narrative (Details)
Fair Value - Separate Accounts Fair Value (Details)
Goodwill And Other Acquired Intangibles - Future Amortization Expense (Details)
Goodwill And Other Intangibles
Goodwill And Other Intangibles (Tables)
Goodwill And Other Intangibles - Goodwill (Details)
Goodwill And Other Intangibles - Intangible Assets (Details)
Goodwill And Other Intangibles - Narrative (Details)
Health Care Costs Payable
Health Care Costs Payable (Tables)
Health Care Costs Payable - Incurred And Paid Health Care Claims Development (Details)
Health Care Costs Payable - Narrative (Details)
Health Care Costs Payable - Reconciliation Of Health Care Costs Payable (Details)
Health Care Costs Payable - Reconciliation Of Health Care Net Incurred And Paid Claims Development To Health Care Costs Payable Liability (Details)
Income Taxes
Income Taxes (Tables)
Income Taxes - Deferred Tax Assets And Liabilities (Details)
Income Taxes - Effective Tax Rate Reconciliation (Details)
Income Taxes - Income Tax Provision (Details)
Income Taxes - Narrative (Details)
Income Taxes - Unrecognized Tax Benefits (Details)
Investments
Investments (Tables)
Investments - Debt Securities (Details)
Investments - Debt Securities By Maturity (Details)
Investments - Mortgage Loans (Details)
Investments - Mortgage Loans Credit Ratings Indicator (Details)
Investments - Narrative (Details)
Investments - Net Investment Income (Details)
Investments - Realized Gains (Details)
Investments - Schedule Of Mortgage Loan Principal Repayments (Details)
Investments - Schedule Of Total Investments (Details)
Investments - Unrealized Loss Position (Details)
Investments - Unrealized Loss Position Maturities (Details)
Leases
Leases (Tables)
Leases - Maturities Of Operating And Finance Lease Liabilities (Details)
Leases - Narrative (Details)
Leases - Summary Of The Components Of Net Lease Cost (Details)
Leases - Supplemental Balance Sheet Information (Details)
Leases - Supplemental Cash Flow Information (Details)
Other Comprehensive Income
Other Comprehensive Income (Details)
Other Comprehensive Income (Tables)
Pension Plans And Other Postretirement Benefits
Pension Plans And Other Postretirement Benefits (Tables)
Pension Plans And Other Postretirement Benefits - Benefit Obligations And Plan Assets (Details)
Pension Plans And Other Postretirement Benefits - Changes In Level 3 Pension Plan Assets (Details)
Pension Plans And Other Postretirement Benefits - Defined Benefit Plans Expected Benefit (Details)
Pension Plans And Other Postretirement Benefits - Fair Value Of Pension Plan Assets (Details)
Pension Plans And Other Postretirement Benefits - Narrative (Details)
Pension Plans And Other Postretirement Benefits - Net Periodic Benefit Costs (Details)
Pension Plans And Other Postretirement Benefits - Weighted Average Assumptions Used (Details)
Reinsurance
Reinsurance (Tables)
Reinsurance - Effects Of Reinsurance (Details)
Reinsurance - Narrative (Details)
Reinsurance - Reinsurance Recoverables (Details)
Segment Reporting
Segment Reporting (Tables)
Segment Reporting - Narrative (Details)
Segment Reporting - Reconciliation From Operating Income To Adjusted Operating Income (Details)
Segment Reporting - Reconciliation Of Financial Measures Of Segments To Consolidated Totals (Details)
Shareholders' Equity
Shareholders' Equity (Tables)
Shareholders' Equity - Accelerated Share Repurchases (Details)
Shareholders' Equity - Dividends (Details)
Shareholders' Equity - Noncontrolling Interests (Details)
Shareholders' Equity - Regulatory Requirements (Details)
Shareholders' Equity - Share Repurchases (Details)
Significant Accounting Policies
Significant Accounting Policies (Policies)
Significant Accounting Policies (Tables)
Significant Accounting Policies - Accounts Receivable (Details)
Significant Accounting Policies - Contract Balances (Details)
Significant Accounting Policies - Disaggregation Of Revenue (Details)
Significant Accounting Policies - Discontinued Operations (Details)
Significant Accounting Policies - Narrative (Details)
Significant Accounting Policies - Property Plant And Equipment (Details)
Significant Accounting Policies - Receivables And Contracted Balances (Details)
Significant Accounting Policies - Restricted Cash (Details)
Significant Accounting Policies - Variable Interest Entities (Details)
Stock Incentive Plans
Stock Incentive Plans (Tables)
Stock Incentive Plans - Restricted Stock Activity (Details)
Stock Incentive Plans - Stock Option And Sar Activity (Details)
Stock Incentive Plans - Stock-Based Compensation Expense And Espp (Details)
Stock Incentive Plans - Valuation And Assumptions (Details)
Ticker: CVS
CIK: 64803
Form Type: 10-K Annual Report
Accession Number: 0000064803-22-000008
Submitted to the SEC: Wed Feb 09 2022 6:37:35 AM EST
Accepted by the SEC: Wed Feb 09 2022
Period: Friday, December 31, 2021
Industry: Retail Drug Stores And Proprietary Stores

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/cvs/0000064803-22-000008.htm